Serving hundreds of leading biopharmaceutical companies globally:

Generated: March 23, 2019

DrugPatentWatch Database Preview

Guerbet Company Profile

« Back to Dashboard

What is the competitive landscape for GUERBET, and what generic and branded alternatives to GUERBET drugs are available?

GUERBET has four approved drugs.

Summary for Guerbet

US Patents:	0
Tradenames:	5
Ingredients:	4
NDAs:	4
Drug Master File Entries:	1

Drugs and US Patents for Guerbet

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Guerbet	LIPIODOL	ethiodized oil	OIL;INTRALYMPHATIC, INTRAUTERINE	009190-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Guerbet	OXILAN-350	ioxilan	INJECTABLE;INJECTION	020316-002	Dec 21, 1995		DISCN	No	No		➤ Sign Up				➤ Sign Up
Guerbet	DOTAREM	gadoterate meglumine	SOLUTION;INTRAVENOUS	204781-004	Mar 20, 2013		RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Guerbet	HEXABRIX	ioxaglate meglumine; ioxaglate sodium	INJECTABLE;INJECTION	018905-002	Jul 26, 1985		DISCN	No	No		➤ Sign Up				➤ Sign Up
Guerbet	DOTAREM	gadoterate meglumine	SOLUTION;INTRAVENOUS	204781-001	Mar 20, 2013		RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Guerbet	DOTAREM	gadoterate meglumine	SOLUTION;INTRAVENOUS	204781-002	Mar 20, 2013		RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Guerbet

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Guerbet	HEXABRIX	ioxaglate meglumine; ioxaglate sodium	INJECTABLE;INJECTION	018905-002	Jul 26, 1985	4,014,986	➤ Sign Up
Guerbet	OXILAN-300	ioxilan	INJECTABLE;INJECTION	020316-001	Dec 21, 1995	4,954,348	➤ Sign Up
Guerbet	OXILAN-350	ioxilan	INJECTABLE;INJECTION	020316-002	Dec 21, 1995	4,954,348	➤ Sign Up
Guerbet	HEXABRIX	ioxaglate meglumine; ioxaglate sodium	INJECTABLE;INJECTION	018905-002	Jul 26, 1985	4,094,966	➤ Sign Up
Guerbet	HEXABRIX	ioxaglate meglumine; ioxaglate sodium	INJECTABLE;INJECTION	018905-002	Jul 26, 1985	4,065,553	➤ Sign Up
Guerbet	HEXABRIX	ioxaglate meglumine; ioxaglate sodium	INJECTABLE;INJECTION	018905-002	Jul 26, 1985	4,065,554	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Guerbet

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.